Comparing the effectiveness of tadalafil and tamsulosin on the control of bladder neck obstruction symptoms in patients with benign prostatic hyperplasia.

Determining and comparing the effectiveness of tadalafil and tamsulosin on the control of bladder neck obstruction symptoms in patients with benign prostatic hyperplasia.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230628058608N1

Enrollment

Registered

2023-09-25

Start date

2023-06-21

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suffering from BPH, suffering from complications of BPH progression in the form of bladder neck obstruction. Enlarged prostate

Interventions

Intervention 1: The first intervention group: receiving tadalafil, tadalafil is prescribed to patients at a dose of 5 mg once a day for two months and half an hour after dinner. Tadalafil belongs to a

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Suffering from BPH, suffering from complications of BPH progression in the form of bladder neck obstruction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Determining and comparing the recovery rate of bladder neck obstruction symptoms in the group treated with tadalafil and tamsulosin based on age. Timepoint: Within two months. Method of measurement: IPSS.	—

Secondary

Measure	Time frame
Bladder neck obstruction-prostate irritation symptoms. Timepoint: Within 2 months. Method of measurement: IPSS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsara negintaji zardak

Islamic Azad University

negintaji.sara@yahoo.com+98 21 2200 6660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026